Pancreatic exocrine insufficiency in diabetes mellitus

Diabetes is disease of both the endo- and exocrine parts of the pancreas. Pancreatic exocrine insufficiency (PEI) can occur in every 2–3 patients with diabetes and affect not only the quality, but also life expectancy. At the same time, the diagnosis and treatment of PEI is not getting enough attention. The endocrinologist, as the main specialist leading patients with diabetes, can diagnose and treat patients with pancreatic exocrine insufficiency and diabetes using adequate doses of pancreatic enzyme replacement therapy (PERT).

1. Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol. 2013;19(42):7258. doi: https://doi.org/10.3748/wjg.v19.i42.7258

2. Pezzilli R. Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian association for the study of the pancreas. World J Gastroenterol. 2013;19(44):7930. doi: https://doi.org/10.3748/wjg.v19.i44.7930

3. Lindkvist B, Domínguez-Muñoz JE, Luaces-Regueira M, et al. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreatology. 2012;12(4):305-310. doi: https://doi.org/10.1016/j.pan.2012.04.006

4. Altay M. Which factors determine exocrine pancreatic dysfunction in diabetes mellitus? World J Gastroenterol. 2019;25(22):2699-2705. doi: https://doi.org/10.3748/wjg.v25.i22.2699

5. Ahmed A, Deep A, Kothari DJ, Sheth SG. Bone disease in chronic pancreatitis. World J Clin Cases. 2020;8(9):1574-1579. doi: https://doi.org/10.12998/wjcc.v8.i9.1574

6. Barkin JA, Barkin JS. Chronic Pancreatitis and Bone Disease. Journal of Clinical Densitometry. 2020;23(2):237-243. doi: https://doi.org/10.1016/j.jocd.2019.08.004

7. Tignor AS, Wu BU, Whitlock TL, et al. High Prevalence of Low-Trauma Fracture in Chronic Pancreatitis. American Journal of Gastroenterology. 2010;105(12):2680-2686. doi: https://doi.org/10.1038/ajg.2010.325

8. Duggan SN, Smyth ND, Murphy A, et al. High Prevalence of Osteoporosis in Patients With Chronic Pancreatitis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2014;12(2):219-228. doi: https://doi.org/10.1016/j.cgh.2013.06.016

9. Guéant J-L, Guéant-Rodriguez R-M, Alpers DH. Vitamin B12 absorption and malabsorption. Vitam Horm. 2022;119:241-274. doi: https://doi.org/10.1016/bs.vh.2022.01.016

10. European Pancreatic Club (EPC), European Digestive Surgery (EDS), European Society for Primary Care Gastroenterology (ESCPG), European Society for Paediatric Gastroenterology H and N (ESPGHAN), European Society for Clinical Nutrition and Metabolism (ESPEN), European Society of Digestive Oncology (ESDO), European Society of Primary Care Gastroenterology (ESPCG). European Guideline on the Diagnosis and Therapy of Pancreatic Exocrine Insufficiency (PEI). 2023. Доступно по: https://europeanpancreaticclub.org/about-us/diagnosis-and-treatment-Guidelines/ Ссылка активна на 09.05.2023

11. Capurso G, Traini M, Piciucchi M, et al. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129-139. doi: https://doi.org/10.2147/CEG.S168266

12. Hart PA, Conwell DL. Diagnosis of Exocrine Pancreatic Insufficiency. Curr Treat Options Gastroenterol. 2015;13(3):347-353. doi: https://doi.org/10.1007/s11938-015-0057-8

13. Singh VK, Haupt ME, Geller DE, et al. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol. 2017;23(39):7059-7076. doi: https://doi.org/10.3748/wjg.v23.i39.7059

14. Smith RC, Smith SF, Wilson J, et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 2016;16(2):164-180. doi: https://doi.org/10.1016/j.pan.2015.12.006

15. Diéguez-Castillo C, Jiménez-Luna C, Prados J, et al. State of the Art in Exocrine Pancreatic Insufficiency. Medicina (B Aires). 2020;56(10):523. doi: https://doi.org/10.3390/medicina56100523

16. Dominguez-Muñoz JE. Diagnosis and treatment of pancreatic exocrine insufficiency. Curr Opin Gastroenterol. 2018;34(5):349-354. doi: https://doi.org/10.1097/MOG.0000000000000459

17. Löhr JM, Dominguez‐Munoz E, Rosendahl J, et al. United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153-199. doi: https://doi.org/10.1177/2050640616684695

18. Kucheryavyy YuA, Bordin DS. A brief review of clinical guidelines for the diagnosis and treatment of exocrine pancreatic insufficiency. Experimental and Clinical Gastroenterology. 2021;(11):5-14. (In Russ.). doi: https://doi.org/10.31146/1682-8658-ecg-195-11-5-14

19. Bordin DS, Dubtsova EA, Vinokurova LV, et al. Functional pancreatic insufficiency after surgical treatment in the light of the latest international recommendations. Alm Clin Med. 2017;45(5):358-365. (In Russ.). doi: https://doi.org/10.18786/2072-0505-2017-45-5-358-365

20. Domínguez-Muñoz JE, D. Hardt P, Lerch MM, Löhr MJ. Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test. Dig Dis Sci. 2017;62(5):1119-1130. doi: https://doi.org/10.1007/s10620-017-4524-z

21. Lankisch PG. Secretion and absorption (methods and functions). Best Pract Res Clin Gastroenterol. 2009;23(3):325-335. doi: https://doi.org/10.1016/j.bpg.2009.03.001

22. Radlinger B, Ramoser G, Kaser S. Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes. Curr Diab Rep. 2020;20(6):18. doi: https://doi.org/10.1007/s11892-020-01304-0

23. Fischer B, Hoh S, Wehler M, et al. Faecal Elastase-1: Lyophilization of Stool Samples Prevents False Low Results in Diarrhoea. Scand J Gastroenterol. 2001;36(7):771-774. doi: https://doi.org/10.1080/003655201300192058

24. Bertolaso C, Groleau V, Schall JI, et al. Fat-Soluble Vitamins in Cystic Fibrosis and Pancreatic Insufficiency. J Pediatr Gastroenterol Nutr. 2014;58(4):443-448. doi: https://doi.org/10.1097/MPG.0000000000000272

25. Johnson CD, Williamson N, Janssen-van Solingen G, et al. Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI). Pancreatology. 2019;19(1):182-190. doi: https://doi.org/10.1016/j.pan.2018.11.013

26. Dominguez-Muñoz JE. Management of pancreatic exocrine insufficiency. Curr Opin Gastroenterol. 2019;35(5):455-459. doi: https://doi.org/10.1097/MOG.0000000000000562

27. Zsóri G, Illés D, Terzin V, et al. Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus: do we need to treat it? A systematic review. Pancreatology. 2018;18(5):559-565. doi: https://doi.org/10.1016/j.pan.2018.05.006

28. Mohapatra S, Majumder S, Smyrk TC, et al. Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy. Pancreas. 2016;45(8):1104-1110. doi: https://doi.org/10.1097/MPA.0000000000000609

29. Hardt PD, Ewald N. Exocrine Pancreatic Insufficiency in Diabetes Mellitus: A Complication of Diabetic Neuropathy or a Different Type of Diabetes? Exp Diabetes Res. 2011;2011:1-7. doi: https://doi.org/10.1155/2011/761950

30. Søfteland E, Poulsen JL, Starup-Linde J, et al. Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics. Eur J Intern Med. 2019;68:18-22. doi: https://doi.org/10.1016/j.ejim.2019.07.021

31. Petersmann A, Müller-Wieland D, Müller UA, et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 2019;127(S 01):S1-7. doi: https://doi.org/10.1055/a-1018-9078

32. Pierzynowski SG, Gregory PC, Filip R, et al. Glucose homeostasis dependency on acini–islet–acinar (AIA) axis communication: a new possible pathophysiological hypothesis regarding diabetes mellitus. Nutr Diabetes. 2018;8(1):55. doi: https://doi.org/10.1038/s41387-018-0062-9

33. Barreto SG, Carati CJ, Toouli J, Saccone GTP. The islet-acinar axis of the pancreas: more than just insulin. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2010;299(1):G10-22. doi: https://doi.org/10.1152/ajpgi.00077.2010

34. American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Supplement_1):S17-38. doi: https://doi.org/10.2337/dc22-S002

35. de la Iglesia-Garcia D, Vallejo-Senra N, Iglesias-Garcia J, et al. Increased Risk of Mortality Associated With Pancreatic Exocrine Insufficiency in Patients With Chronic Pancreatitis. J Clin Gastroenterol. 2018;52(8):e63-72. doi: https://doi.org/10.1097/MCG.0000000000000917

36. Perbtani Y, Forsmark CE. Update on the diagnosis and management of exocrine pancreatic insufficiency. F1000Res. 2019;8:1991. doi: https://doi.org/10.12688/f1000research.20779.1

37. Ivashkin VT, Mayev IV, Okhlobystin AV, et al. Diagnostics and treatment of pancreatic exocrine insufficiency: clinical guidelines of the Russian gastroenterological association. Rus J Gastroenterol Hepatol Coloproctol. 2018;28(2):72-100. (In Russ.) doi: https://doi.org/10.22416/1382-4376-2018-28-2-72-100

38. Hammer HF. Pancreatic Exocrine Insufficiency: Diagnostic Evaluation and Replacement Therapy with Pancreatic Enzymes. Digestive Diseases. 2010;28(2):339-343. doi: https://doi.org/10.1159/000319411

39. Rossiiskoe obshchestvo khirurgov, Rossiiskaia Gastroenterologicheskaia Assotsiatsiia, Assotsiatsiia khirurgov-gepatologov, Endoskopicheskoe obshchestvo «REndO». Khronicheskii pankreatit. Klinicheskie rekomendatsii 2020. (In Russ.). Доступно по: https://cr.minzdrav.gov.ru/schema/273_4 Ссылка активна на 09.05.2023

40. Soiuz pediatrov Rossii, Assotsiatsiia meditsinskikh genetikov, Rossiiskoe respiratornoe obshchestvo, Rossiiskoe transplantologicheskoe obshchestvo, Assotsiatsiia detskikh vrachei Moskovskoi oblasti. Kistoznyi fibroz (mukovistsidoz). Klinicheskie rekomendatsii. 2021. (In Russ.). Доступно по: https://cr.minzdrav.gov.ru/schema/372_2 Ссылка активна на 09.05.2023

41. Shimizu K, Ito T, Irisawa A, et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2021. J Gastroenterol. 2022;57(10):709-724. doi: https://doi.org/10.1007/s00535-022-01911-6

42. Domínguez-Muñoz JE, Phillips M. Nutritional Therapy in Chronic Pancreatitis. Gastroenterol Clin North Am. 2018;47(1):95-106. doi: https://doi.org/10.1016/j.gtc.2017.09.004

43. Layer P, Kashirskaya N, Gubergrits N. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency. World J Gastroenterol. 2019;25(20):2430-2341. doi: https://doi.org/10.3748/wjg.v25.i20.2430

44. Roberts KJ, Schrem H, Hodson J, et al. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. HPB. 2017;19(10):859-867. doi: https://doi.org/10.1016/j.hpb.2017.05.009

45. Partelli S, Frulloni L, Minniti C, et al. Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. Digestive and Liver Disease. 2012;44(11):945-951. doi: https://doi.org/10.1016/j.dld.2012.05.017

46. Domínguez-Muñoz JE, Nieto-Garcia L, López-Díaz J, et al. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. BMC Cancer. 2018;18(1):534. doi: https://doi.org/10.1186/s12885-018-4439-x

47. Gubergrits NB, Byelyayeva NV, Klochkov АY, et al. Enzyme replacement therapy, life quality and expectancy of patients with chronic pancreatitis and exocrine pancreatic insufficiency. Bulletin of the Club of Pancreatologists. 2018;41(3):10-16. doi: https://doi.org/10.33149/vkp.2018.03.02

48. Jackuliak P, Payer J. Osteoporosis, Fractures, and Diabetes. Int J Endocrinol. 2014;2014:1-10. doi: https://doi.org/10.1155/2014/820615

49. Ewald N, Bretzel RG, Fantus IG, et al. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab Res Rev. 2007;23(5):386-391. doi: https://doi.org/10.1002/dmrr.708

50. Ebert R, Creutzfeldt W. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia. 1980;19(3):198-204. doi: https://doi.org/10.1007/BF00275269

51. Knop FK, Vilsbøll T, Larsen S, et al. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. American Journal of Physiology-Endocrinology and Metabolism. 2007;292(1):E324-330. doi: https://doi.org/10.1152/ajpendo.00059.2006

52. O’Keefe SJD, Cariem AK, Levy M. The Exacerbation of Pancreatic Endocrine Dysfunction by Potent Pancreatic Exocrine Supplements in Patients with Chronic Pancreatitis. J Clin Gastroenterol. 2001;32(4):319-323. doi: https://doi.org/10.1097/00004836-200104000-00008

53. Mohan V, Poongothai S, Pitchumoni CS. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. International Journal of Pancreatology. 1998;24(1):19-22. doi: https://doi.org/10.1007/BF02787526

54. Whitcomb DC, Bodhani A, Beckmann K, et al. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus. Pancreas. 2016;45(5):679-686. doi: https://doi.org/10.1097/MPA.0000000000000514

55. Adler G, Mundlos S, Kuhnelt P et al., New Methods for Assessment of Enzyme Activity. Digestion 1993, 54 p: 3-9.